Offidani, M., Corvatta, L., Morè, S., Nappi, D., Martinelli, G., Olivieri, A., & Cerchione, C. (2021). Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments. Front Oncol.
Citação norma ChicagoOffidani, Massimo, Laura Corvatta, Sonia Morè, Davide Nappi, Giovanni Martinelli, Attilio Olivieri, and Claudio Cerchione. "Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments." Front Oncol 2021.
Citação norma MLAOffidani, Massimo, et al. "Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments." Front Oncol 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.